Arnica

Arnica montana L. belongs to Asteraceae (Compositae), the daisy or sunflower family, and was first published by Linnaeus in Species Plantarum in 1753 (Kew’s Plants of the World Online). EMA’s assessment report describes Arnica as a genus of about 30 species, of which A. montana is the one accepted for medicinal use in the European Pharmacopoeia. Kew gives its native range as Europe alone, from Portugal and Spain through France, Italy, Switzerland, Austria, Germany, the Netherlands, Belgium, and Scandinavia to Poland, Romania, and Ukraine, with an introduced population in the western Himalaya, and it recognizes two subspecies, subsp. montana and subsp. atlantica. The IUCN describes the species as endemic to Europe. Older American texts complicate the picture: King’s American Dispensatory (1898) placed A. montana in Siberia and the north-western United States as well, and MSKCC still lists East Asia and North America. North America has its own arnicas, several of which King’s listed as related species, and US food regulations name A. fulgens, A. sororia, and A. cordifolia alongside A. montana, so not every plant called arnica is A. montana.

It is a hairy perennial growing from a brown, horizontal rhizome with many slender roots. Mrs Grieve’s A Modern Herbal (1931) describes the leaves as forming a flat rosette, from which a flower stalk rises one to two feet high. The Dispensatory of the United States (1918) describes these basal leaves as ovate, entire, and fringed with fine hairs, and the stem leaves as smaller and lance-shaped, usually in two opposite pairs, a trait preserved in the plant’s old synonym Doronicum oppositifolium. The stem ends in one to three flower heads about 3 cm across (King’s, quoting the US Pharmacopoeia), each with a disk of many small tubular florets and a ring of about 14 to 16 strap-shaped yellow ray florets, three-toothed at the tip, which give the head its slightly ragged look. Grieve calls the flowers orange-yellow. The fruits are slender, dark, ribbed achenes crowned with a pappus of whitish bristles. Hollmann and colleagues (PLOS One 2020) note that the plumed fruits are dispersed by wind but are heavy and do not travel far, and that the flowers are pollinated by many kinds of insects.

Arnica is a specialist of poor, acidic soils. Hollmann and colleagues describe it as calcifuge (lime-avoiding) and light-demanding, a characteristic species of nutrient-poor grasslands and heaths; in lowland Hesse, Germany, it had died out on 9 of the 32 sites they studied within the previous 15 years, the lost sites had more nitrogen-rich soils, and in the greenhouse fertilizer plus grass competition cut seedling numbers. The medicinal part is the flower head. EMA’s assessment report puts its sesquiterpene lactones at 0.3–1.0%, mainly esters of helenalin and 11,13-dihydrohelenalin, alongside flavonoids (0.4–0.6%) and essential oil (0.2–0.35%); the European Pharmacopoeia requires at least 0.4% sesquiterpene lactones. Central European plants are rich in helenalin esters, while a Spanish chemotype contains mainly dihydrohelenalin esters. Helenalin (PubChem CID 23205, C15H18O4) and its relatives are regarded as the main active constituents (MSKCC) and as strong skin sensitizers (EMA, citing Reider), though MSKCC notes that other compounds such as polyacetylenes may add to the allergy risk. Quality problems are old: the 1918 Dispensatory reports arnica flowers adulterated with calendula, Inula, and other yellow daisies, and fly larvae (Trypeta arnicivora) in the flower bases, which the Swiss and German pharmacopoeias required to be removed.

Arnica’s common names describe a mountain plant with a sting in its tail. MSKCC lists mountain tobacco, leopard’s bane, wolf’s bane, and mountain arnica, and the Dispensatory of the United States (1918) explains the tobacco name: the powdered flowers and leaves were used as a snuff to provoke sneezing, and the people of Savoy and the Vosges were said to use them in place of tobacco. German names it records include Wohlverleih, Gemsblume, and Fallkraut. EMA’s assessment report notes that a herbal by Tabernaemontanus attributed a wound-healing effect to arnica in 1613, and that over the centuries it was used for bruising, injuries, varicose veins, phlebitis, gout, rheumatism, indigestion, and heart complaints. Grieve wrote that in countries where arnica grows wild it had long been a popular remedy, and that in the North American colonies the flowers were preferred to the root. She also recorded a homeopathic arnica tincture given for epilepsy and seasickness, an early sign of the homeopathic career arnica would later have.

Nineteenth-century American physicians used arnica both inside and out, with growing unease. King’s American Dispensatory (1898), the textbook of the Eclectic physicians, recommended small internal doses as a stimulant in typhoid and other fevers, palsy, chronic rheumatism, ‘heart-strain,’ and backache, and external use of the infusion or diluted tincture to disperse bruising and as a dressing for cuts and contusions; it also described an arnica plaster. The same book warned that strong preparations could cause erysipelas-like inflammation, with blistering when used on wounds, and that large internal doses caused vomiting, purging, spasms, difficulty breathing, and coma, adding that two fluid ounces of the tincture had caused death. The Dispensatory of the United States (1918) recorded severe and fatal poisonings, saw no sufficient reason to believe arnica was valuable in internal diseases, and noted that it was largely used externally for bruises and sprains. Grieve (1931) likewise recommended the tincture only for sprains, bruises, wounds, and chilblains on unbroken skin, warned that repeated applications could cause severe inflammation, and recorded many severe cases of poisoning, especially from internal use.

Modern regulation drew the same line between skin and mouth. Germany’s Commission E monograph of 1984 accepted a wide range of external uses, including bruises, sprains, swelling around fractures, rheumatic muscle and joint pain, mouth and throat inflammation, boils, insect bites, and superficial phlebitis, but excluded internal use because of possible risks (EMA). WHO and ESCOP monographs followed, and on 6 May 2014 EMA’s herbal committee adopted a narrower European monograph covering bruises, sprains, and localized muscular pain. A draft revision released for consultation in April 2025 proposes adding insect bites and small boils. Homeopathy, developed in the late 1700s (FDA), adopted arnica as a signature remedy, and by 1998 Ernst and Pittler called it the homeopathic remedy most frequently studied in placebo-controlled trials. In the United States, FDA says no homeopathic product is FDA-approved; its December 2022 guidance sets out a risk-based enforcement approach, and the Federal Trade Commission announced in November 2016 that homeopathic health claims need the same scientific evidence as other drug claims. US food regulations permit arnica flowers only as a natural flavoring in alcoholic beverages.

Arnica’s anti-inflammatory story centers on its sesquiterpene lactones, and above all on helenalin. In laboratory studies summarized by EMA, Lyss and colleagues showed that helenalin blocks NF-κB, a master switch that turns on genes for many inflammatory messengers, in T cells, B cells, and epithelial cells at micromolar concentrations, while 11,13-dihydrohelenalin was much weaker. Their 1998 paper in the Journal of Biological Chemistry found that helenalin acts by directly alkylating, or chemically modifying, the p65 subunit of NF-κB, and described it as the first anti-inflammatory agent shown to work by directly modifying NF-κB. Whole preparations behave similarly in cells: a pharmacy arnica tincture completely blocked NF-κB binding to DNA in T cells at 5 µg/ml, whereas an arnica gel needed 50 µg/ml, and activity tracked sesquiterpene lactone content (EMA, citing Klaas 2002). A methanol extract lowered the inflammatory enzymes iNOS and COX-2 in mouse immune cells (EMA), and MSKCC cites a study in which an arnica flower tincture suppressed MMP1 and MMP13, enzymes that break down cartilage, in human and bovine joint cartilage cells.

Whether enough of these compounds reaches the tissue under a bruise is less certain. In pig-ear skin, helenalin and dihydrohelenalin esters from arnica tinctures and a gel penetrated the outer layer of the skin, about ten times better from whole extracts than as isolated compounds, and penetration from a gel fell off after four hours while ointments kept delivering (EMA, citing Wagner and colleagues 2004). EMA notes that specific data on absorption, distribution, metabolism, and elimination are not available. The same compounds affect blood platelets: in blood from healthy volunteers, helenalin and dihydrohelenalin inhibited collagen-induced platelet aggregation and thromboxane formation in a concentration-dependent way (Schröder and colleagues 1990, cited by EMA and MSKCC). MSKCC calls the clinical relevance unknown, but it is one reason for caution with blood thinners. EMA concluded that the pharmacology only weakly supports the traditional uses, that knowledge of bioavailability is limited, and that no constituent with known therapeutic activity could be defined for the preparations it lists.

The chemistry has a double edge. Lass and colleagues (cited by EMA) found that arnica tinctures suppressed NF-κB at high concentrations but stimulated immune cells at low ones, and in mice, arnica tinctures did not induce contact allergy and even dampened reactions to a strong sensitizer. In people, though, contact allergy to arnica is well documented, and Reider and colleagues described its sesquiterpene lactones as strongly sensitizing. Homeopathic arnica cannot work through any of this chemistry. Homeopathy rests on the 1700s ideas that like cures like and that more dilute remedies are more potent (FDA). In one German trial the remedy was a 30X dilution, which Brinkhaus and colleagues define as one part in 10 to the 30th power, and NCCIH notes that many homeopathic products are so diluted that no molecules of the original substance remain. NCCIH adds that several key concepts of homeopathy are not consistent with fundamental scientific concepts, which is one reason positive trials of homeopathic arnica deserve careful scrutiny.

Bruises, sprains, and localized muscle pain are arnica’s officially recognized uses in Europe. EMA’s 2014 monograph accepts specific tinctures and extracts in creams, gels, ointments, and soaked dressings as traditional herbal medicines for these complaints in adults and adolescents, “exclusively based upon long-standing use.” The committee reviewed several trials and saw a possible effect on pain and bruising, but could not draw firm conclusions because of small numbers and missing controls, and judged that the trials could not support well-established use. A 2025 draft revision proposes adding inflammation from insect bites and small boils, echoing part of the older German Commission E list. MSKCC summarizes the clinical evidence as a few trials suggesting topical arnica helps osteoarthritis and reduces bruising compared with placebo or low-strength vitamin K, with mixed postoperative results. EMA also cites a 2001 trial in 100 people with chronic venous insufficiency in which an arnica gel, used alongside standardized water therapy, improved venous measurements more than placebo, but that is a single study.

Osteoarthritis has the most convincing data. Widrig and colleagues (Rheumatology International 2007) randomized 204 people with painful, radiologically confirmed osteoarthritis of the finger joints, recruited from 20 practices and clinics in three Swiss cantons, to an arnica gel made from a fresh-plant tincture (50 g per 100 g of gel) or a 5% ibuprofen gel for 21 days, double-blind. Pain and hand function improved similarly in both groups, with no differences in any secondary measure, and the authors concluded that the arnica gel was not inferior to ibuprofen. Cochrane’s 2013 review of topical herbal therapies (Cameron and Chrubasik), working from the 174 participants analyzed, rated this as moderate-quality evidence that arnica gel probably works about as well as an NSAID gel, with a pain difference of about 4 points on a 100-point scale; total adverse events were somewhat more common with arnica (13% versus 8%), a difference that was not statistically significant. There was no placebo group, so the trial cannot show how much either gel beat a dummy cream, and it is a single trial of one product. An open, uncontrolled six-week study of a similar gel in 79 people with knee osteoarthritis (Knuesel and colleagues, Advances in Therapy 2002) reported better WOMAC pain, stiffness, and function scores, but without a comparison group.

Bruising after procedures is the other big topical use, and here the trials disagree. Leu and colleagues (British Journal of Dermatology 2010) made four standard bruises with a pulsed-dye laser on the inner arms of each of 16 volunteers (EMA) and treated one each with 20% arnica ointment, 5% vitamin K, 1% vitamin K with retinol, or white petrolatum, under occlusion twice a day for two weeks. Arnica bruises improved more than those treated with petrolatum or the weak vitamin K mix, but not more than with 5% vitamin K. An earlier 19-patient trial of an arnica gel before or after laser treatment found no difference from the gel base (EMA, citing Alonso 2002). After surgery, van Exsel and colleagues (Plastic and Reconstructive Surgery 2016) randomized 136 patients having upper-eyelid surgery to 10% arnica ointment or placebo on one side; appearance, swelling, bruising, redness, pain, and satisfaction did not differ, and neither ointment beat the untreated eyelid. In 108 rhinoplasty patients, arnica cream reduced bruising and swelling more than no treatment and about as much as a mucopolysaccharide polysulfate cream (Simsek and colleagues 2016), but there was no placebo. Ho and colleagues (Dermatologic Surgery 2016) found improvement in only 4 of 13 randomized trials of oral or topical arnica and judged the data insufficient to support its use after procedures. For exercise soreness, Adkison and colleagues (Annals of Pharmacotherapy 2010) had 53 people apply arnica cream to one leg and placebo to the other after calf raises; the arnica legs were more painful at 24 hours, with no difference later.

Homeopathic arnica is popular before and after surgery and has been tested often. Ernst and Pittler (Archives of Surgery 1998) found eight placebo-controlled trials, most burdened with severe methodological flaws, and concluded that they do not suggest homeopathic arnica is more effective than placebo. Later trials split. In 64 adults having carpal tunnel surgery, arnica 30C or 6C tablets taken for a week before and two weeks after the operation made no difference to pain, bruising, swelling, or painkiller use (Stevinson and colleagues 2003). In three German knee-surgery trials with 319 patients in total, 30X globules showed a trend toward less swelling that was significant only after cruciate ligament reconstruction (Brinkhaus and colleagues 2006). Among 190 adults having their tonsils removed, those taking arnica 30c had a slightly larger fall in pain scores over two weeks (28.3 versus 23.8 points), but only 111 returned questionnaires and painkiller use did not differ (Robertson and colleagues 2007). In 29 face-lift patients, the bruised area was smaller on two of four days measured, with no difference in bruise color or in how patients and staff judged the bruising (Seeley and colleagues 2006).

Pooled analyses reflect that inconsistency. Gaertner, Baumgartner, and Walach (Frontiers in Surgery 2021) analyzed 28 comparisons from 23 publications; across placebo-controlled trials the effect was small (Hedges’ g of 0.18) and not statistically significant (p = 0.059), and a larger effect against active comparators shrank toward zero when only randomized trials were considered, although the authors concluded that arnica has a small effect comparable to anti-inflammatory drugs. A 2016 review by Iannitti and colleagues (American Journal of Therapeutics) was more positive, while noting that the doses and preparations used produced substantial differences in outcomes. More broadly, NCCIH says there is little evidence that homeopathy is effective for any specific health condition, citing a 2015 Australian government assessment that found no reliable evidence of effectiveness. Herbal arnica taken by mouth has no accepted modern use: Commission E and EMA both restrict arnica medicines to the skin, and MSKCC notes that arnica’s other uses have not been studied to see if they work.

EMA’s 2014 monograph covers four alcoholic preparations of the flower heads: two tinctures made from 1 part flowers to 10 parts 60–70% ethanol, a stronger 1:5 tincture, and a liquid extract of fresh flowers (1:20 in 50% ethanol). For adults and adolescents, creams and ointments containing 20–25% tincture are applied in a thin layer two to three times a day, semi-solid products containing 50% fresh-flower extract two to four times a day, and dressings soaked in 2.5 ml of tincture three to four times a day. Use is on intact skin only, and EMA asks people to see a doctor if symptoms persist after three to four days. The 2025 draft revision adds a warm compress made by steeping 2 g of dried flowers in 100 ml of boiling water for 10–15 minutes, tincture diluted with 3 to 10 parts water, and a sunflower-oil extract, and it stresses that tinctures should be diluted and kept away from the eyes and mucous membranes. Trials used comparable strengths: the hand osteoarthritis gel contained 50 g of fresh-plant tincture per 100 g, the laser-bruise ointment 20% arnica, and the eyelid-surgery ointment that did not help 10%.

Homeopathic arnica is a different product, even when the box looks similar. FDA advises looking for the word “Homeopathic,” ingredients listed by Latin or scientific names, and dilutions such as 1X, 6X, or 2C. In the trials above, products ranged from 6C and 30C tablets to 30X globules, taken several times a day for up to three weeks around surgery, and higher numbers mean greater dilution, not more arnica. A homeopathic label does not guarantee extreme dilution, however: FDA notes that some homeopathic products have been found to contain measurable amounts of active ingredients, and NCCIH warns that some may contain substantial amounts that could cause side effects and drug interactions. In 2013 Venkatramani and colleagues (Cutaneous and Ocular Toxicology) described a patient who developed severe vomiting and then severe, lasting loss of vision in both eyes after accidentally swallowing a large quantity of an Arnica-30 homeopathic medicine. They diagnosed toxic optic neuropathy and warned that, although homeopathic medicines are generally considered safe because of their very low concentrations, Arnica-30 may be neurotoxic if taken in large quantities.

Practical points: choose a product that names Arnica montana flower and states its strength, and keep it for bruises, sprains, and sore muscles on unbroken skin. Before regular use, try a little on a small patch of skin and watch for itching or redness, especially if you react to other daisy-family plants. Do not apply it to cuts, grazes, open blisters, or weeping eczema, or near the eyes, and avoid smearing large amounts over big areas, particularly if you take warfarin. Stop at the first sign of a rash. Never make arnica tea or drink a tincture: herbal arnica for the skin and homeopathic pellets for the mouth are not interchangeable, and a bottle of tincture within a child’s reach is a poisoning risk. If a sprain or bruise is not clearly improving after three or four days, as EMA advises, see a doctor rather than applying more.